Cerevance logo — Cerevance a neuroscience company

Cerevance

Cerevance a neuroscience company

Founded 2016 United States Boston, United States 35 employees Series C Total: $224.00M Biotechnology, Health and Wellness +2

General Information

Company Name Cerevance
Founded Year 2016
Location United States Boston, United States +2
Employees 35
Industries Biotechnology, Health and Wellness, Life Sciences +1
Funding Stage Series C
Social

Get notified when Cerevance moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Cerevance recently secured a Series C funding round while simultaneously completing patient enrollment for its pivotal Phase 3 ARISE trial across the U.S., Europe, the UK, and Australia. This significant clinical and geographical expansion, coupled with the CEO's active participation in neuroscience thought leadership, signals the company's rapid acceleration towards advanced pipeline development and potential market entry. These developments collectively underscore Cerevance's strategic advancement in de-risking its neurodegenerative therapies.

Signal Types
Funding Expansion Product Development Thought Leadership
Strategic Labels
Clinical Development Global Expansion Scientific Leadership
Next Move: Data Readout
·
Impact: 9/10
·
Ideal For: Biopharma VCs — Series C+

About Cerevance

Cerevance is a biotechnology startup that was founded in 2016 and is based in the United States. The company recently secured a substantial $47.00M Series B investment on 25 April 2024. The investors in this round included GV, Lightstone Ventures, Agent Capital, Bioluminescence Ventures, DermBiont, Inc., MQB Partners, Gates Frontier Fund, and LifeRock Ventures. Cerevance's focus on biotechnology and the significant investment it has attracted underpin the potential for the company to make a significant impact in the industry. As a burgeoning player in the biotechnology sector, Cerevance's recent investment underscores the confidence that key market players have in the company's innovative approach and future prospects.

Taxonomy: neuroscience, pharmaceuticals, mental health, drug discovery, neurological disorders, brain research, psychiatric diseases, biopharmaceuticals, genomics, neurodegenerative diseases

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 7
Investor Investor Investor Investor Investor
•••• ••••
01 May 2026
Series B •••••• 8
Investor Investor Investor Investor Investor Investor
•••• ••••
01 Apr 2024
Series B •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• ••••
01 Feb 2023
Series B •••••• 8
Investor Investor Investor Investor Investor Investor
•••• ••••
01 Jul 2020
Series B •••••• 5
Investor Investor Investor Investor
•••• ••••
01 Apr 2020

View All 9 Funding Rounds

Cerevance Alternatives & Competitors

Cerevance vs

Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.

Post Ipo Debt
376 employees
Biotechnology, Health Care
Cerevance vs
Vandria SA
Vandria SA Switzerland

We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic...

Grant
14 employees
Manufacturing, Pharmaceutical
Cerevance vs

A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenera...

Series Unknown
1 employees
Biotechnology

FAQ About Cerevance

Cerevance a neuroscience company
Cerevance was founded in 2016.
Cerevance is headquartered in Boston, United States.
Cerevance operates in the following industries: Biotechnology, Health and Wellness, Life Sciences, Pharmaceutical.
Cerevance has approximately 35 employees.
Cerevance has completed 9 funding rounds, raising a total of $224.00M. The latest funding stage is Series C.
Top alternatives and competitors to Cerevance include Intercept Pharmaceuticals, Vandria SA, CENSO BIOTECHNOLOGIES LTD, Rubedo Life Sciences, Antlia Bioscience, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cerevance and Intercept Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cerevance and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy